| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |